Long COVID-19 gastrointestinal related disorders and traditional Chinese medicine: A network target-based approach.

Publication date: Feb 29, 2024

The significant number of individuals impacted by the pandemic makes prolonged symptoms after COVID-19 a matter of considerable concern. These are numerous and affect multiple organ systems. According to the World Health Organization (WHO), prolonged gastrointestinal issues are a crucial part of post-COVID-19 syndrome. The resulting disruption of homeostasis underscores the need for a therapeutic approach based on compounds that can simultaneously affect more than one target/node. The present review aimed to check for nutraceuticals possessing multiple molecular mechanisms helpful in relieving Long COVID-19-specific gastrointestinal symptoms. Specific plants used in Keywords Chinese Medicine (TCM) expected to be included in the WHO Global Medical Compendium were selected based on the following criteria: (1) they are widely used in the Western world as natural remedies and complementary medicine adjuvants; (2) their import and trade are regulated by specific laws that ensure quality and safety (3) have the potential to be beneficial in alleviating intestinal issues associated with Long COVID-19. Searches were performed in PubMed, Elsevier, Google Scholar, Scopus, Science Direct, and ResearchGate up to 2023. Cinnamomum cassia, Glycyrrhiza uralensis, Magnolia officinalis, Poria cocos, Salvia miltiorrhiza, Scutellaria baicalensis, and Zingiber officinalis were identified as the most promising for their potential impact on inflammation and oxidative stress. Based on the molecular mechanisms of the phytocomplexes and isolated compounds of the considered plants, their clinical use may lead to benefits in gastrointestinal diseases associated with Long COVID-19, thanks to a multiorgan and multitarget approach.

Concepts Keywords
Chinese gastrointestinal tract
Gastrointestinal long COVID-19
Global multitarget approach
Homeostasis phytotherapy
Magnolia post-acute COVID-19 syndrome
traditional Chinese medicine


Type Source Name
disease MESH Long COVID
disease MESH COVID-19
disease VO organ
disease VO organization
disease MESH syndrome
disease IDO quality
drug DRUGBANK Scutellaria baicalensis root
disease MESH inflammation
disease MESH oxidative stress
disease MESH gastrointestinal diseases

Original Article

(Visited 1 times, 1 visits today)